Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease

NCT02194985 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amicus Therapeutics